VSL Pharmaceuticals, Inc.
VSL Pharmaceuticals, Inc., commonly referred to as VSL, is a leading biotechnology company headquartered in the United States. Founded in 2000, VSL has established itself as a pioneer in the development of high-quality probiotic products, particularly known for its flagship offering, VSL#3, a medical food designed to manage specific gastrointestinal disorders. With a strong focus on research and innovation, VSL operates primarily in the healthcare industry, catering to both consumers and healthcare professionals. The company has achieved significant milestones, including numerous clinical studies that underscore the efficacy of its products. VSL's commitment to quality and scientific validation positions it as a trusted name in the probiotic market, making it a preferred choice for those seeking effective gastrointestinal health solutions.
DitchCarbon Score
How does VSL Pharmaceuticals, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
VSL Pharmaceuticals, Inc.'s score of 3 is lower than 100% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
VSL Pharmaceuticals, Inc.'s reported carbon emissions
VSL Pharmaceuticals, Inc., headquartered in the US, currently does not report any carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Furthermore, there are no documented reduction targets or climate pledges associated with the company. This lack of data suggests that VSL Pharmaceuticals may not have established formal commitments to reduce its carbon footprint or engage in climate initiatives at this time. As the industry increasingly prioritises sustainability, VSL Pharmaceuticals may need to consider developing and communicating its climate strategies to align with broader environmental goals.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
VSL Pharmaceuticals, Inc. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
